Resolution of Hypersplenism and Pancytopenia in Common Variable Immunodeficiency Patient After Partial Splenic Artery Embolization: A Case Report and Review of Literature

Safiah Hussain Sumayli, Latifah Rashed Al Shekaili, Sulaiman Saleh Al Gazlan, Farrukh Sheikh, Hassan Al Rayes, Hasan Hamdan Al Dhekri, Agha Muhhamad Rehan Khaliq, Rand Khalid Arnaout

Abstract


Common variable immunodeficiency (CVID) is the second most prevalent primary immunodeficiency disorder following selective immunoglobulin A (IgA) deficiency but it is more complicated clinically. It causes a wide spectrum of symptoms and signs affecting several systems of the body. CVID is mostly a humoral immunodeficiency with cell-mediated immunity being affected in some patients leading to both autoimmunity and malignancy adding to the immunodeficiency, which makes the management of these patients very complicated. Gastrointestinal tract (GIT) and bone marrow are commonly affected organs by both autoimmunity and malignancy in the context of CVID. In this paper, we present a case of CVID who presented with pancytopenia secondary to hypersplenism and failed both intravenous immunoglobulins (IVIG) and steroids treatment. She underwent partial splenic artery embolization as an alternative procedure to total splenectomy to preserve some splenic function and avoid surgical total splenectomy. Partial splenic artery embolization leads to dramatic improvement in platelets, hemoglobin and white cell count after the procedure without further compromising her immune system.



J Hematol. 2015;4(2):174-177
doi: http://dx.doi.org/10.14740/jh168w

Keywords


Hyersplenism; Pancytopenia; Common variable immunodeficiency; Splenic artery embolization

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!